Search research articles
Contact Us
Filters
Showing results (191-200 of 207) with videos related to
Page
of 21
Sort By:
Geroscience
|
May 12, 2026
Elevated levels of circulating plasma sPDGFRβ in cognitively impaired APOE4 carriers
Abhay P Sagare, Trevor Lohman, Ivan Ramirez, et al.
Neuron
|
January 23, 2015
Blood-brain barrier breakdown in the aging human hippocampus
Axel Montagne, Samuel R Barnes, Melanie D Sweeney, et al.
Plos One
|
November 22, 2013
Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study
Michael G Harrington, Jiarong Chiang, Janice M Pogoda, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 18, 2020
A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid
Melanie D Sweeney, Abhay P Sagare, Maricarmen Pachicano, et al.
Plos One
|
July 15, 2020
Correction: Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
Samuel Asanad, Michele Fantini, William Sultan, et al.
Plos One
|
May 30, 2020
Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
Samuel Asanad, Michele Fantini, William Sultan, et al.
La Radiologia Medica
|
September 11, 2025
<sup>68</sup>Ga-DOTATATE PET/CT versus MRI in neuroendocrine liver metastases: a comprehensive per-lesion analysis
Alexander Herold, Azadeh Hajati, Yihan Cao, et al.
Ebiomedicine
|
June 18, 2026
CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial
Hussein N Yassine, Sara Ghasem Pour, Marlene Juarez, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 24, 2023
Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia
H N Yassine, I C Arellanes, A Mazmanian, et al.
Ebiomedicine
|
July 22, 2020
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
Isabella C Arellanes, Nicholas Choe, Victoria Solomon, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 207) with videos related to
Sort By:
Page
of 21
Geroscience
|
May 12, 2026
Elevated levels of circulating plasma sPDGFRβ in cognitively impaired APOE4 carriers
Abhay P Sagare, Trevor Lohman, Ivan Ramirez, et al.
Neuron
|
January 23, 2015
Blood-brain barrier breakdown in the aging human hippocampus
Axel Montagne, Samuel R Barnes, Melanie D Sweeney, et al.
Plos One
|
November 22, 2013
Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study
Michael G Harrington, Jiarong Chiang, Janice M Pogoda, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 18, 2020
A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluid
Melanie D Sweeney, Abhay P Sagare, Maricarmen Pachicano, et al.
Plos One
|
July 15, 2020
Correction: Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
Samuel Asanad, Michele Fantini, William Sultan, et al.
Plos One
|
May 30, 2020
Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
Samuel Asanad, Michele Fantini, William Sultan, et al.
La Radiologia Medica
|
September 11, 2025
<sup>68</sup>Ga-DOTATATE PET/CT versus MRI in neuroendocrine liver metastases: a comprehensive per-lesion analysis
Alexander Herold, Azadeh Hajati, Yihan Cao, et al.
Ebiomedicine
|
June 18, 2026
CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial
Hussein N Yassine, Sara Ghasem Pour, Marlene Juarez, et al.
The Journal of Prevention of Alzheimer'S Disease
|
October 24, 2023
Baseline Findings of PreventE4: A Double-Blind Placebo Controlled Clinical Trial Testing High Dose DHA in APOE4 Carriers before the Onset of Dementia
H N Yassine, I C Arellanes, A Mazmanian, et al.
Ebiomedicine
|
July 22, 2020
Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial
Isabella C Arellanes, Nicholas Choe, Victoria Solomon, et al.
Page
of 21